Skip to main content
. 2020 Oct 20;10:17820. doi: 10.1038/s41598-020-74568-x

Figure 2.

Figure 2

Modeling-based RGT approach in 4 representative patients. Gt, genotype; SOF/VEL, sofosbuvir/velpatasvir; SOF/LED, sofosbuvir/ledipasvir; ELB/GRZ, elbasvir/grazoprevir; GLE/PIB, glecaprevir/Pibrentasvir. Estimated viral kinetic parameters of patients in whom time to cure was predicted by modeling are shown in Table 2.